Investor Tamarack Advisers, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Tamarack Advisers, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-11-22 13D 5,514,515 154,044
2023-06-22 13D/A STRM / Streamline Health Solutions, Inc. 5,128,308 5,514,515
2022-12-01 13D/A STRM / Streamline Health Solutions, Inc. 5,036,063 5,128,308
2021-03-23 13D/A STRM / Streamline Health Solutions, Inc. 5,036,063 5,036,063
2021-03-23 13D/A STRM / Streamline Health Solutions, Inc. 4,342,134 5,036,063
2021-02-16 13G/A ISEE / IVERIC bio Inc 850,000 850,000
2021-02-16 13G/A ISEE / IVERIC bio Inc 2,650,000 850,000
2020-02-14 13G/A 67424L100 / Obalon Therapeutics Inc 2,100,000
2020-02-14 13G ISEE / IVERIC bio Inc 2,650,000
2020-02-14 13G/A CORV / Correvio Pharma Corp. (Canada) 2,125,000 2,500,000
2019-12-13 13D STRM / Streamline Health Solutions, Inc. 4,342,134 4,342,134
2019-11-08 13G/A STRM / Streamline Health Solutions, Inc. 1,950,000 4,342,134
2019-02-15 13G/A CRME / Cardiome Pharma Corp.
2019-02-15 13G/A STRM / Streamline Health Solutions, Inc. 1,950,000 1,950,000
2019-02-15 13G CORV / Correvio Pharma Corp. (Canada) 2,125,000 2,125,000
2019-02-15 13G 67424L100 / Obalon Therapeutics Inc 2,100,000
2019-02-14 13G CORV / Correvio Pharma Corp. (Canada) 2,125,000
2019-02-14 13G/A CRME / Cardiome Pharma Corp. 1,875,000
2019-02-14 13G/A STRM / Streamline Health Solutions, Inc. 1,050,000 1,950,000
2018-02-14 13G/A CRME / Cardiome Pharma Corp. 1,825,000 1,875,000
2018-02-14 13G/A STRM / Streamline Health Solutions, Inc. 1,138,000 1,050,000
2017-02-15 13G/A IMPR / Imprivata Inc. 1,746,000 0
2017-02-15 13G/A CORI / Corium International, Inc. 1,385,000 737,242
2017-02-15 13G CRME / Cardiome Pharma Corp. 1,825,000
2017-02-15 13G/A US29266S3040 / Endologix, Inc. 4,475,000 0
2016-02-11 13G CORI / Corium International, Inc. 1,385,000
2016-02-11 13G US29266S3040 / Endologix, Inc. 4,475,000
2016-02-11 13G IMPR / Imprivata Inc. 1,746,000
2016-02-11 13G STRM / Streamline Health Solutions, Inc. 1,138,000